Louisiana State Employees Retirement System Invests $2.07 Million in HealthEquity, Inc. $HQY

Louisiana State Employees Retirement System acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 24,800 shares of the company’s stock, valued at approximately $2,073,000.

Several other hedge funds also recently bought and sold shares of HQY. Capricorn Fund Managers Ltd bought a new position in shares of HealthEquity in the fourth quarter worth about $6,926,000. Congress Asset Management Co. raised its stake in HealthEquity by 36.3% during the 4th quarter. Congress Asset Management Co. now owns 101,816 shares of the company’s stock valued at $9,327,000 after purchasing an additional 27,102 shares during the period. Norges Bank purchased a new position in HealthEquity in the 4th quarter worth approximately $66,927,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in HealthEquity in the 4th quarter worth approximately $4,381,000. Finally, Westfield Capital Management Co. LP boosted its stake in HealthEquity by 13.7% in the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after purchasing an additional 235,794 shares during the period. Institutional investors own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HQY shares. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. JPMorgan Chase & Co. decreased their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. Finally, Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Price Performance

HealthEquity stock opened at $90.32 on Wednesday. The company has a market cap of $7.55 billion, a price-to-earnings ratio of 33.83, a PEG ratio of 1.48 and a beta of 0.21. The firm’s fifty day moving average is $85.45 and its 200 day moving average is $84.64. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Activity

In other news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 13,081 shares of company stock valued at $1,193,000 in the last ninety days. Insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.